CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Purnanand Sarma

Former CEO, Immunome

Search every verified Purnanand Sarma interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Purnanand Sarma, former president and CEO of Immunome, discussed the company's antibody discovery platform in a July 2022 episode of the Business of Biotech podcast. He described the platform as leveraging memory B cells from patients who have successfully fought diseases, such as cancer or COVID-19, to identify novel therapeutic antibodies and their antigen targets. Sarma stated that the process does not begin with a hypothesis about which target is important, but instead relies on the human immune system to guide discovery, comparing the approach to selecting an "all-star team" of trained immune cells. During the interview, Sarma also offered advice on handling clinical holds, emphasizing that patient safety should be the foremost consideration in such situations. He noted that differences of opinion can arise between companies and regulatory agencies, but acknowledged that agencies have a responsibility to ensure safety. Sarma also reflected on his career approach, stating that he tends to remain committed to a company over the long term rather than frequently changing roles.

Recent appearances

  • Purnanand Sarma's Vision for TiE Boston as As Eco System Builder, Engaging All 240 Charter Members

    July 02, 2024 · 📺 INE News & Multimedia

    BOSTON — Veteran Life Sciences entrepreneur Purnanad Sharma assumed the role of the 14th president of TiE Boston on July 1, 2024, for a two-year term, replacing Yash Shah. In an exclusive Face-to-Face interview with INDIA New England News, Mr. Sarma talks about his vision for TiE Boston as a dominant eco system builder and engaging all 240 Charter Members. Mr. Sarma is Consulting CEO at GelMEDIX Inc, and until most recently, served as the President, CEO, and Board Member of Immunome (IMNM:NASDAQ), which he successfully led through an IPO in 2020, a large pharma transaction with $2 billion+ p…

    Watch on YouTube ↗

  • Antibody Cocktails With Immunome's Dr. Purnanand Sarma

    July 06, 2022 · 📺 Life Science Connect

    Immunome CEO Purnanand Sarma, Ph.D. joins the Business of Biotech for a discussion on precision antibodies and his company's discovery platform, which identifies novel therapeutic antibodies and their antigen targets by leveraging highly educated memory B cells from patients who have learned to fight off their disease. It’s kind of like picking an all-star team of players who have been in the game, and who are well-trained to win. On today's episode we'll learn how they’re discovered, how they’re developed, and how they’re applied in cancer and coronavirus. #businessofbiotech #biopharma #biot…

    Watch on YouTube ↗

  • Corona Virus - Meditation and Medication | Madhu Babu Prakya & Purnanand Sarma | S Cube TV National

    July 03, 2020 · 📺 S Cube TV National

    Watch Discussion on Corona Virus - Meditation and Medication. Can we ever control it ? An AStro Medical Discussion. Madhu babu Prakya B.Sc,MBA(UK),LLM(UK) Purnanand D Sarma, PhD, President, CEO and Board Member Immunome, Inc., #MadhuBabuPrakya #PurnanandDSarma #AstroMedicalDiscussion #Meditation #Medication #LiveInteractions #ScubeTV #ScubeInterview

    Watch on YouTube ↗

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →